BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:HEC53856 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of HEC53856\, from ClinicalTrials.gov estima
 tes.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07891377-930@assetmemo.bio
DTSTAMP:20261121T005440Z
DTSTART;VALUE=DATE:20280229
DTEND;VALUE=DATE:20280301
SUMMARY:HEC53856: Phase 2 readout est. (NCT07891377)
DESCRIPTION:HEC53856\, phase 2.\nStudy: HEC53856 Tablets for Chemotherapy-i
 nduced Anemia in Non-myeloid Malignancies\nEstimated primary completion: F
 ebruary 2028. This is a ClinicalTrials.gov estimate\, not a confirmed read
 out date\, and it can move.\nDrug page: https://assetmemo.bio/drug/hec5385
 6#upcoming-events\nRegistry record: https://clinicaltrials.gov/study/NCT07
 891377
URL:https://assetmemo.bio/drug/hec53856#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
